Claritev (NYSE:CTEV) Stock Price Up 7.7% Following Analyst Upgrade

Key Points

• Claritev shares rose 7.7% to about $38.04 after Wells Fargo raised its price target from $22 to $30, while maintaining an “equal weight” rating.
• Analyst sentiment remains mixed: Canaccord Genuity raised its target to $43 with a “buy” rating, while other firms issued hold or sell ratings. The consensus rating is “Hold,” with an average price target of $42.83.
• SVP William B. Mintz sold 8,431 shares worth approximately $288,677, reducing his ownership by 10.59%; institutional investors collectively own 87.15% of the company.

Claritev (NYSE:CTEV - Get Free Report) shares shot up 7.7% on Thursday after Wells Fargo & Company raised their price target on the stock from $22.00 to $30.00. Wells Fargo & Company currently has an equal weight rating on the stock. Claritev traded as high as $38.05 and last traded at $38.04. Approximately 42,764 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 164,040 shares. The stock had previously closed at $35.32.

A number of other research firms have also issued reports on CTEV. Zacks Research lowered shares of Claritev from a "hold" rating to a "strong sell" rating in a research note on Friday, July 17th. Wall Street Zen upgraded shares of Claritev from a "sell" rating to a "hold" rating in a research note on Saturday, August 8th. Barclays assumed coverage on shares of Claritev in a report on Friday, April 24th. They set an "overweight" rating and a $28.00 price target for the company. Canaccord Genuity Group lifted their price target on shares of Claritev from $37.00 to $43.00 and gave the stock a "buy" rating in a research note on Monday. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Claritev in a report on Wednesday, June 24th. Six equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $42.83.

Insider Buying and Selling at Claritev

In other news, SVP William B. Mintz sold 8,431 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $34.24, for a total value of $288,677.44. Following the completion of the sale, the senior vice president directly owned 71,195 shares of the company's stock, valued at $2,437,716.80. This represents a 10.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 7.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Claritev

A number of institutional investors have recently modified their holdings of CTEV. FAS Wealth Partners Inc. raised its holdings in shares of Claritev by 49.5% during the 1st quarter. FAS Wealth Partners Inc. now owns 46,477 shares of the company's stock valued at $759,000 after purchasing an additional 15,380 shares in the last quarter. Bank of America Corp DE boosted its holdings in Claritev by 146.6% in the first quarter. Bank of America Corp DE now owns 97,795 shares of the company's stock worth $1,598,000 after purchasing an additional 58,133 shares in the last quarter. RBF Capital LLC boosted its holdings in Claritev by 0.8% in the first quarter. RBF Capital LLC now owns 135,314 shares of the company's stock worth $2,211,000 after purchasing an additional 1,127 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new position in Claritev during the first quarter worth $38,000. Finally, State of Wyoming increased its position in Claritev by 239.2% during the first quarter. State of Wyoming now owns 2,018 shares of the company's stock worth $33,000 after buying an additional 1,423 shares during the last quarter. Institutional investors and hedge funds own 87.15% of the company's stock.

Claritev Stock Up 7.7%

The company's 50-day simple moving average is $29.32 and its 200 day simple moving average is $23.86. The stock has a market capitalization of $648.58 million, a price-to-earnings ratio of -2.24 and a beta of 0.74.

Claritev Company Profile

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source